Clinical trials: Gambling

Pathological Gambling

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

• Completed
• Age: 18 to 75 years
• Phase 2
• Results posted

This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.

Trial name

NCT01215357

Testing

Ecopipam

Where

4 sites in United States

Volunteers

34 people

Sponsor

Emalex Biosciences Inc.